Jeffrey A. Leerink

Chairman and CEO

Jeffrey A. Leerink founded Leerink Swann in 1995, creating the first independent healthcare research firm providing investors with direct access to analysts, physicians and medical professionals. In 1999, the firm ranked 30^th in Inc. magazine's "America's 500 Fastest-Growing Private Companies." Under Mr. Leerink's leadership, the firm has grown to become the premier healthcare investment bank, providing investment banking, institutional sales and trading, equity research, asset management and strategic advisory services for institutional, life sciences and high-net-worth clients. For the past seven years, the firm has earned "Best of the Boutiques" honors from Institutional Investor magazine.

Mr. Leerink actively supports a number of charitable organizations. He sits on the boards of Big Brothers of Massachusetts Bay and the United Way of Massachusetts Bay and Merrimack Valley. Mr. Leerink is the Co-Chairman of the 2007 Campaign for United Way of Massachusetts and Merrimack Valley. In addition, he is an ardent supporter of (BIOS), the Bermuda Biological Station for Research and a member of the International Game Fishing Association. Mr. Leerink formerly served as an Alumni Advisor to The Union College Board of Trustees. He was born in Massachusetts, and received his B.A. in Economics from Union College.

Daniel B. Dubin, M.D

Vice Chairman of Leerink Swann and Founder of MEDACorp

Daniel B. Dubin has been an advisor to institutional investors and corporate life sciences clients since 1996. Dr. Dubin is also a member of the Management Committee and Chair of the Commitment Committee at Leerink Swann. He was an instructor in Dermatology at Harvard Medical School and has held staff appointments at the Brigham and Women's Hospital and Dana Farber Cancer Institute. While at Brigham and Women's Hospital, he served as Ambulatory Medical Director of Clinical Dermatology and as a member of the Clinical Executive Committee.

Dr. Dubin is a graduate of Dartmouth College and Harvard Medical School and completed both an internship in internal medicine and a residency in Dermatology at Massachusetts General Hospital. He has published over 30 manuscripts in medical journals and textbooks and performed a NIH training fellowship at the Harvard Skin Disease Research Center. He serves as a Director of Eleme Medical, a private cellulite treatment device company and is the former Chairman of MetaWorks, Inc.

Joseph Gentile

Chief Administrative Officer

Joseph Gentile joined the Firm in 2007 as Chief Administrative Officer. Mr. Gentile was formerly CFO, Global Investment Bank at Lehman Brothers, where he directed the accounting and financial needs within the Fixed Income division, the largest operating division of Lehman Brothers.

Prior to that, he served as CFO of the Global Corporate and Investment Bank at Bank of America, where he led the Capital Markets Division. Previously, Mr. Gentile spent more than 10 years with J.P. Morgan in various financial management positions, including Global Head of Financial Risk Management. He holds a B.S. in accounting and MBA in finance from St. John's University.

Timothy A.G. Gerhold

General Counsel

Timothy Gerhold joined the Firm in 2006 as its General Counsel and Senior Managing Director or the Compliance and Legal Group. Prior to joining the Firm, Mr. Gerhold was the General Counsel and Head of Compliance of BancBoston Capital, one of the largest bank-affiliated private equity groups in the United States. Before that, Mr. Gerhold held a number of positions in the Law Office of BankBoston Financial Corporation, including Group Head of the Capital Markets Group and Group Head of the Financial Services Group. Previously, Mr. Gerhold practiced law at Goodwin Proctor LLP. Mr. Gerhold received his B.A. from Carleton College, and his J.D. from Yale Law School.

John McPhee

Managing Director, Head of Private Client Group

John McPhee has been with Leerink Swann from its inception in 1995. He is a graduate of Bentley College with a B.S. in Finance. Mr. McPhee is a Registered Securities Principal and a Registered Options Principal.

Andrew Newman

Treasurer, Senior Managing Director of Operations

Andrew Newman has been associated with Leerink Swann since 1995 and is responsible for Operations & Technology. He served as Chief Financial Officer from 1995 to 2000. Prior to joining the Company, Mr. Newman was a Registered Representative with Fechtor Detwiler, a regional broker/dealer in Boston; and previously a Commercial Loan Officer and Field Examiner with Baybanks. Mr. Newman has a B.S. in Finance from the University of Massachusetts, Dartmouth.

David Ogens

Senior Managing Director, Head of Investment Banking

David Ogens joined the Firm in 2005. Prior to joining the Firm, he had spent most of his investment-banking career at Goldman Sachs, where he was a Managing Director in the Boston office and previously was Global Head of the High Technology Investment Banking Group working out of New York. In addition to his investment banking experience, Mr. Ogens also co-founded a healthcare technology and services company focused on managing physician networks through the use of sophisticated point of care technology. He also was the co-founder of a private wealth management company serving ultra-high-net-worth families. He earned his MBA from the University of Virginia's Darden Graduate School of Business and a B.A. from the University of Virginia.

Michael Weintraub

Senior Managing Director and Head of Corporate Development and Strategy

Michael Weintraub joined the Firm in 2007 as Senior Managing Director and Head of Corporate Development & Strategy. Integral to the corporate development and strategy of the business is the firm's unique knowledge platform. In this capacity, Mr. Weintraub leads Leerink Swann's information and knowledge-ware hub, which includes MEDACorp, as well as several emerging assets. Additionally, Mr. Weintraub leads the firm's corporate marketing function.

His background includes 25 years of executive management experience in the healthcare technology, information services and consulting arenas. Mr. Weintraub has held senior leadership positions in several start-up and rapid growth organizations, focused on the application of innovative decision support technology, information assets and analytic services across the healthcare spectrum. Most recently, he was President & CEO of PharMetrics from 2001-2006. PharMetrics was a venture-funded company providing healthcare business intelligence information solutions to the pharmaceutical, biotechnology, medical device, provider, payor, employer and consumer markets. PharMetrics was acquired by IMS Health in 2005. Previously, Mr. Weintraub was Senior Vice President & COO of eLoyalty, Vice President & General Manager at The MEDSTAT Group, Senior Vice President & Officer at MediQual Systems and a Director at Amherst Associates.

He holds a B.A. in Economics from Brandeis University and an MBA from Harvard Business School.

Stephen Weiss

Senior Managing Director, Head of Institutional Equities

Stephen Weiss's career in institutional equities spans more than 20 years and includes some of the most prestigious firms on Wall Street. Prior to joining the Firm, he was Co-Founder and Managing Member of Short Hills Capital Partners, LLC. For five years, he served as Managing Director and Head of U.S. Cash Sales for Lehman Brothers, where he led a 125-person team selling U.S. Research Product, as well as the distribution of non-dollar product in the U.S. Prior to that, Mr. Weiss was Global and U.S. Research Product Manager for Salomon Brothers, responsible for content, creativity and quality of product. Mr. Weiss began his career as an institutional salesperson for Oppenheimer & Company and later worked at Salomon Brothers. Mr. Weiss also worked in a senior management capacity at SAC Capital, LLC and was a tax attorney before entering the securities industry.